Title:
Phage display In biotechnology and drug discovery
Series:
Drug discovery series /3
Publication Information:
Boca Raton, FL : CRC Press, 2005
Physical Description:
xviii, 748 p. : ill. ; 24 cm.
ISBN:
9780824754662
Added Author:
Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010230343 | QR342 P424 2005 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
The first and only guide to showcase the impact of phage display technology on drug discovery, this reference details the theories, principles, and methods impacting the field and demonstrates applications for peptide phage display, protein phage display, and the development of novel antibodies. Highlighting the current and future role of phage display in the development of protein therapeutics, this book provides a comprehensive overview that will prove invaluable to anyone researching recombinant antibodies.
Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.
Table of Contents
Foreword | p. v |
Preface | p. vii |
Contributors | p. xv |
1 Filamentous Bacteriophage Structure and Biology | p. 1 |
I Introduction | p. 1 |
II Taxonomy and Genetics | p. 3 |
III Viral Gene Products | p. 5 |
IV Structure of the Virion | p. 11 |
V Filamentous Bacteriophage Life Cycle | p. 18 |
VI Phage Library Diversity | p. 34 |
VII Biological Bottlenecks: Sources of Library Censorship | p. 35 |
VIII Quantitative Diversity Estimation | p. 41 |
IX Improved Library Construction | p. 45 |
References | p. 47 |
2 Vectors and Modes of Display | p. 63 |
I Introduction | p. 63 |
II Most Display Vectors are Based on Filamentous Phage | p. 65 |
III General Cloning Vectors Based on Filamentous Phage | p. 71 |
IV Classification of Filamentous Phage Display Systems | p. 75 |
V Phage f1-The First Phage-Display Vector | p. 77 |
VI Low DNA Copy Number Display Vectors Based on fd-tet | p. 78 |
VII Diversity of Type 3 Vectors | p. 80 |
VIII Type 8 Vectors: First Lessons | p. 81 |
IX Mosaic Display in Type nn Systems | p. 83 |
X Mosaic Display in Phagemid Systems | p. 89 |
XI Vectors for C-Terminal Display | p. 91 |
XII Phage Proteins as Constraining Scaffolds | p. 93 |
XIII Conclusion | p. 95 |
References | p. 98 |
3 Methods for the Construction of Phage-Displayed Libraries | p. 111 |
I Introduction | p. 111 |
II Oligonucleotide-Directed Mutagenesis | p. 112 |
III Random Mutagenesis | p. 123 |
IV Combinatorial Infection and Recombination | p. 126 |
V DNA Shuffling | p. 129 |
References | p. 135 |
4 Selection and Screening Strategies | p. 143 |
I Introduction | p. 143 |
II General Considerations | p. 144 |
III The Selection Process | p. 146 |
IV Selections Methods | p. 150 |
References | p. 161 |
5 Phage Libraries for Developing Antibody-Targeted Diagnostics and Vaccines | p. 165 |
I Introduction | p. 165 |
II Phage-Display Libraries as Tools for Epitope Discovery | p. 170 |
III Diagnostics | p. 179 |
IV Phage Libraries for Epitope Mapping | p. 187 |
V Phage Display Libraries for Vaccine Development | p. 200 |
VI Developing Immunogens from Peptide Leads | p. 218 |
VII Summary | p. 235 |
VIII Conclusion | p. 238 |
IX Abbreviations | p. 239 |
References | p. 240 |
6 Exploring Protein-Protein Interactions Using Peptide Libraries Displayed on Phage | p. 255 |
I Introduction | p. 255 |
II Extracellular Protein-Protein Interactions | p. 256 |
III Intracellular Protein-Protein Interactions | p. 268 |
IV Conclusions | p. 274 |
References | p. 275 |
7 Substrate Phage Display | p. 283 |
I Overview | p. 283 |
II Introduction | p. 284 |
III The Concept of Substrate Phage Display | p. 285 |
IV Application of Substrate Phage Display to Cancer Research | p. 294 |
V Conclusions | p. 305 |
References | p. 308 |
8 Mapping Intracellular Protein Networks | p. 321 |
I Introduction | p. 321 |
II Domain-Mediated Interactions | p. 323 |
III Nondomain Mediated Protein-Protein Interactions | p. 336 |
IV Software for Identifying Candidate Interacting Partners | p. 336 |
V Analyzing Predicted Interactions | p. 337 |
VI Relevance to Biotechnology and Drug Discovery | p. 338 |
References | p. 340 |
9 High Throughput and High Content Screening Using Peptides | p. 347 |
I Introduction | p. 347 |
II Peptides as Enzyme Inhibitors | p. 348 |
III Peptides as Conformational Probes | p. 355 |
IV Summary | p. 376 |
References | p. 377 |
10 Engineering Protein Folding and Stability | p. 385 |
I Protein Redesign and Design | p. 385 |
II Early Combinatorial Studies Aimed at Repacking the Cores of Proteins | p. 387 |
III Phage Display in Engineering Protein Stability | p. 390 |
IV A Worked Example: Repacking the Hydrophobic Core of Ubiquitin | p. 397 |
V Studies that Build on the Original Methods | p. 406 |
VI Summary | p. 408 |
References | p. 409 |
11 Identification of Natural Protein-Protein Interactions with cDNA Libraries | p. 415 |
I Overview | p. 415 |
II Introduction | p. 416 |
III Cloning Vectors | p. 417 |
IV Display of cDNA Libraries on Phage Surface | p. 420 |
V Problems Associated with the Display of cDNA Libraries on Phage Surface | p. 425 |
VI Adaptability of Phage Display to High-Throughput Screening Technology | p. 427 |
VII Conclusions | p. 428 |
References | p. 429 |
12 Mapping Protein Functional Epitopes | p. 441 |
I Introduction | p. 441 |
II Single Point Alanine Mutagenesis | p. 443 |
III Combinatorial Site-Specific Mutagenesis | p. 447 |
IV Other Approaches to Phage-Displayed Functional Epitope Mapping | p. 455 |
V Conclusion | p. 456 |
References | p. 456 |
13 Selections for Enzymatic Catalysts | p. 461 |
I Introduction | p. 461 |
II Selection Methods | p. 464 |
III Discussion | p. 482 |
References | p. 486 |
14 Antibody Humanization and Affinity Maturation Using Phage Display | p. 493 |
I Introduction | p. 493 |
II Humanization Using Phage Display | p. 497 |
III In Vitro Affinity Maturation of Antibodies | p. 501 |
IV Emerging Approaches | p. 519 |
V Conclusions | p. 520 |
References | p. 521 |
15 Antibody Libraries from Immunized Repertoires | p. 529 |
I Introduction | p. 529 |
II Immune Antibody Library Construction | p. 538 |
III Immune Antibody Library Selection | p. 570 |
IV The Future | p. 622 |
References | p. 624 |
16 Naive Antibody Libraries from Natural Repertoires | p. 659 |
I Introduction | p. 659 |
II Construction of Naive Libraries | p. 660 |
III Applications of Naive Libraries | p. 674 |
IV Summary | p. 700 |
References | p. 700 |
17 Synthetic Antibody Libraries | p. 709 |
I Introduction | p. 709 |
II The Scripps Research Institute | p. 711 |
III The Medical Research Council | p. 714 |
IV Morphosys | p. 720 |
V Genentech | p. 726 |
VI Conclusions | p. 732 |
References | p. 733 |
Index | p. 741 |